
What We're Reading: Canada Sets Biologics Naming Rules; Heath Trackers and Employee Privacy; IVF and Embryos
Health Canada announced that all biologics, including biosimilars, will be identified by their brand names and nonproprietary names without the addition of a product-specific suffix; a boom in the use of connected health and fitness monitors that are connected to insurance plans and employers is providing an increasingly valuable source of workforce health intelligence, raising privacy concerns, and adding a new dimension to the worker-employer relationship; as the number of spare embryos from in vitro fertilization rises, giving birth with donated embryos is becoming more popular, although many of the agencies that provide donated embryos are supported by federal funds and restrict whom they help.
Health Canada Announces Suffix-Free Biologic and Biosimilar Naming Convention
Connected Health Trackers May Give Data to Insurance Companies, Employers
Who Gets Donated Embryos Through Federal Funds May Leave Some Out
Health Canada announced that all biologics, including biosimilars, will be identified by their brand names and nonproprietary names without the addition of a product-specific suffix,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.